EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pharmacological Blockade of Hypoxia-Driven Autophagy: A Therapeutic Strategy to Limit Endothelial Activation and Thrombosis

Propanna Bandyopadhyay, Pragati Ramesh Kumbhar, Yash T. Katakia, Syamantak Majumder, Sudeshna Mukherjee, Gautam Singhvi, Rajdeep Chowdhury

ACS Pharmacology & Translational Science · 2026-08-14 · 9 (8) · 2184-2197

DOI: 10.1021/acsptsci.5c00770 ↗
AbstractBibliografische Angaben

Abstract

Abstract Thrombosis, a major underlying cause of cardiovascular disorders, is frequently initiated by endothelial cell (EC) activation, which facilitates platelet adhesion and subsequent clot formation. Although vascular injury is a well-established trigger, accumulating evidence implicates hypoxia as an additional determinant of thrombus development. In our previous study, we demonstrated that hypoxia associated with high altitude can promote autophagy-induced platelet aggregation. However, the contribution of ECs to such thrombosis under comparable hypoxic conditions (10%) remains poorly understood. In this study, using ECs isolated from rat aorta ex vivo, we show that hypoxia-inducible factor-1 alpha (HIF-1α), a key transcription factor, regulates autophagy and subsequent EC activation. Importantly, pharmacological inhibition of HIF-1α-mediated autophagy, repositioning the FDA-approved drug chloroquine (CQ), led to attenuated expression of P-Selectin, ICAM1, VCAM1 and consequent reduced platelet adhesion to ECs. Further mechanistic analysis revealed that autophagy modulates the NF-κB signaling pathway, in which P65 transcriptionally regulates the adhesion molecules ICAM1 and VCAM1 by binding to their upstream promoter elements under hypoxic conditions. In addition, using a rat IVC ligation model, we found that CQ not only attenuates thrombus formation but also suppresses VCAM1 expression, validating its antithrombotic potential. In summary, our findings suggest that hypoxia-induced HIF-1α activation promotes an autophagy-dependent NF-κB signaling cascade, thereby contributing to endothelial activation and thrombus formation. Furthermore, CQ’s ability to disrupt this pathway underscores the therapeutic potential of targeting endothelial autophagy to mitigate hypoxia-associated thrombosis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →